Dual Monoclonal Antibody Therapy for a Severe Asthma Patient

IntroductionOmalizumab, the first biological treatment for severe allergic bronchial asthma, has been on the market for more than a decade. Omalizumab was initially considered to be an IgE-blocking agent, and therefore, an inhibitor of the Th2 (allergic or adaptive) cascade. More recently, other mon...

全面介紹

Saved in:
書目詳細資料
Main Authors: Christian Domingo (Author), Xavier Pomares (Author), Anisi Morón (Author), Ana Sogo (Author)
格式: 圖書
出版: Frontiers Media S.A., 2020-09-01T00:00:00Z.
主題:
在線閱讀:Connect to this object online.
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

因特網

Connect to this object online.

3rd Floor Main Library

持有資料詳情 3rd Floor Main Library
索引號: A1234.567
復印件 1 可用